News

Renovion

Apr 305 min read

Renovion Announces Positive Top-Line Results from Phase 2 CLIMB Study of ARINA-1 (RVN-301) in Patients with Non-Cystic Fibrosis Bronchiectasis

Elevated QOL in NCFBE patients with ARINA-1 treatment. Robust data show significant symptom improvement surpassing clinical thresholds.

Renovion

Jan 112 min read

Renovion Completes Enrollment of Adult Patients in Phase 2 CLIMB Study in Bronchiectasis

Renovion Inc., a company focused on restoring lung health in patients with bronchiectasis, announces patient enrollment for Phase 2 trial.

Renovion

Apr 7, 20222 min read

Renovion Provides Regulatory Update and Initiation of Clinical Program in Non-CF Bronchiectasis

Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for rare, chronic, and serious lung diseases...